Annual Retained Earnings
-$558.57 M
-$241.60 M-76.22%
December 31, 2024
Summary
- As of March 12, 2025, NAMS annual retained earnings is -$558.57 million, with the most recent change of -$241.60 million (-76.22%) on December 31, 2024.
- During the last 3 years, NAMS annual retained earnings has fallen by -$519.31 million (-1322.72%).
- NAMS annual retained earnings is now -7373.12% below its all-time high of -$7.47 million, reached on December 1, 2020.
Performance
NAMS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$558.57 M
-$92.18 M-19.76%
December 31, 2024
Summary
- As of March 12, 2025, NAMS quarterly retained earnings is -$558.57 million, with the most recent change of -$92.18 million (-19.76%) on December 31, 2024.
- Over the past year, NAMS quarterly retained earnings has dropped by -$92.18 million (-19.76%).
- NAMS quarterly retained earnings is now -2795.60% below its all-time high of $20.72 million, reached on June 30, 2022.
Performance
NAMS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NAMS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.2% | -19.8% |
| 3 y3 years | -1322.7% | -19.8% |
| 5 y5 years | -7373.1% | -19.8% |
NAMS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1322.7% | at low | -2795.6% | at low |
| 5 y | 5-year | -7373.1% | at low | -2795.6% | at low |
| alltime | all time | -7373.1% | at low | -2795.6% | at low |
NewAmsterdam Pharma Company NV Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$558.57 M(+76.2%) | -$558.57 M(+19.8%) |
| Sep 2024 | - | -$466.39 M(+3.7%) |
| Jun 2024 | - | -$449.75 M(+9.5%) |
| Mar 2024 | - | -$410.74 M(+29.6%) |
| Dec 2023 | -$316.97 M | -$316.97 M(+50.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$211.33 M(+50.9%) |
| Dec 2022 | -$140.04 M(+256.7%) | -$140.04 M(-775.8%) |
| Jun 2022 | - | $20.72 M(-152.8%) |
| Dec 2021 | -$39.26 M(+425.3%) | -$39.26 M |
| Dec 2020 | -$7.47 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual retained earnings?
- What is the all time high annual retained earnings for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual retained earnings year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly retained earnings?
- What is the all time high quarterly retained earnings for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly retained earnings year-on-year change?
What is NewAmsterdam Pharma Company NV annual retained earnings?
The current annual retained earnings of NAMS is -$558.57 M
What is the all time high annual retained earnings for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual retained earnings is -$7.47 M
What is NewAmsterdam Pharma Company NV annual retained earnings year-on-year change?
Over the past year, NAMS annual retained earnings has changed by -$241.60 M (-76.22%)
What is NewAmsterdam Pharma Company NV quarterly retained earnings?
The current quarterly retained earnings of NAMS is -$558.57 M
What is the all time high quarterly retained earnings for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly retained earnings is $20.72 M
What is NewAmsterdam Pharma Company NV quarterly retained earnings year-on-year change?
Over the past year, NAMS quarterly retained earnings has changed by -$92.18 M (-19.76%)